B. Myrup

发表

Fibrinolysis in insulin-dependent diabetic patients with and without nephropathy

P. Rossing, J. Jespersen, C. Kluft, 1996 .

Platelet aggregation and fatty acid composition of platelets in type 1 diabetes mellitus.

K. Winther, B. Myrup, C. Bregengaard, 1991, Clinica chimica acta; international journal of clinical chemistry.

Decreased Platelet Activity Without Change in Fibrinolytic Activity After Low Dosages of Fish Oil

J. Mehlsen, C. Høy, B. Myrup, 1993, Angiology.

Aspects of haemostatic function in healthy subjects with microalbuminuria--a potential atherosclerotic risk factor.

K. Borch-Johnsen, G. Jensen, J. Jensen, 1995, Thrombosis research.

Cardiovascular risk factors during estrogen-norethindrone and cholecalciferol treatment.

B. Myrup, P. McNAiR, G. Jensen, 1992, Archives of internal medicine.

Fish Oil in Diabetic Nephropathy

H. Parving, P. Rossing, F. Nielsen, 1996, Diabetes Care.

Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy.

P. Rossing, J. Jespersen, C. Kluft, 1996, Thrombosis research.

Endothelial function and serum lipids in the course of developing microalbuminuria in insulin-dependent diabetes mellitus.

T. Deckert, B. Myrup, E. Mathiesen, 1994, Diabetes research.

Effects of heparin and aminoguanidine on glomerular basement membrane thickening in diabetic rats

H. Yokoyama, P. Oturai, T. Deckert, 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus

B. Feldt-Rasmussen, J. Jespersen, C. Kluft, 1995, The Lancet.

Primary haemostasis in thyroid disease

B. Myrup, J. Faber, C. Bregengård, 1995, Journal of internal medicine.

Increased Tissue Factor Pathway Inhibitor Activity in IDDM Patients With Nephropathy

H. Yokoyama, P. Rossing, B. Myrup, 1996, Diabetes Care.

n-3 fatty acids in adipose tissue and coronary artery disease are inversely related.

B. Myrup, K. Seidelin, B. Fischer-Hansen, 1992, The American journal of clinical nutrition.

No Effect of Unfractioned or Low Molecular Weight Heparin Treatment on Markers of Vascular Wall and Hemostatic Function in Incipient Diabetic Nephropathy

J. Jespersen, C. Kluft, T. Deckert, 1997, Diabetes Care.

The effect of the relationship between tissue-type plasminogen activator and plasminogen activator inhibitor type 1 on tissue-type plasminogen activator activity in insulin-dependent diabetes mellitus

P. Rossing, J. Jespersen, C. Kluft, 1994 .

Lack of effect of fish oil supplementation on coagulation and transcapillary escape rate of albumin in insulin-dependent diabetic patients with diabetic nephropathy

P. Rossing, J. Jespersen, H. Parving, 2001, Scandinavian journal of clinical and laboratory investigation.

Treatment of enteritis in chronic granulomatous disease with granulocyte colony stimulating factor

P. Mortensen, B. Myrup, N. Valerius, 1998, Gut.

Heparin, a possible therapy for diabetic complications: the effect on mesangial and myomedial cells in vivo and in vitro, especially in relation to extracellular matrix.

H. Yokoyama, P. Oturai, T. Deckert, 1995, Journal of diabetes and its complications.

Procoagulant activity and intimal dysfunction in IDDM

P. Rossing, J. Jespersen, C. Kluft, 2006, Diabetologia.

Release of endothelium‐associated proteins into blood by injection of heparin in normal subjects and in patients with Type 1 diabetes

H. Yokoyama, T. Olivecrona, B. Myrup, 2004, Diabetic medicine : a journal of the British Diabetic Association.

Concentration changes during venous occlusion of proteins with affinity for extracellular matrix in insulin-dependent diabetes mellitus A sign of vascular damage in patients with diabetic nephropathy?

P. Rossing, J. Jespersen, C. Kluft, 1999 .

Raised Serum Sialic Acid Concentration Precedes Onset of Microalbuminuria in IDDM: A 10-year follow-up study

J. Jensen, H. Yokoyama, T. Deckert, 1996, Diabetes Care.